Pieter Stalenhoef is a longstanding New England equity analyst who also happens to be an active member of the Boston Security Analysts Society. Currently working in the role of a Financial Planner for Highland Financial Group, he worked for a reputed firm focusing on media, consumer, and health care verticals.

A recent article Pieter Stalenhoef came across helped him understand how a continued robust outlook for the health care sector has returned positive results in 17 out of the last 20 years. He explains that the main reason behind these magnificent results is there is less competition in comparison to a lot of other sectors, thanks to the high barriers to entry. Pieter emphasizes that biotech has led the health care on the path to continued growth and that according to an estimate, 30 biotech companies are expected to have reached or maintained profitability in 2019, with demand being driven by an aging population, obesity, and issues related to diet and lifestyle changes. He considers biotech solutions for cancer, Alzheimer's disease, multiple sclerosis, and thrombosis as other areas of growth.

About Pieter Stalenhoef

Pieter Stalenhoef is an aspiring novelist who is currently working for Highland Financial Group as a Financial Planner. He is a Bachelor in Business Administration from the University of Vermont and a Master of Investment Management from Boston University. He has been a member of the Boston Security Analysts Society for more than 18 years now. In addition to that, Pieter has also made an appearance on Barron's Magazine for his interviews about Femsa, a Mexican convenience store chain, and MBT, a Russian telecom company.